Posted by & filed under Company Analysis, Growth & Valuation, Personal Finance.

Description: In an interview with Bloomberg Editor-in-Chief John Micklethwait, one of the people most responsible for helping to vaccinate the world against Covid-19 discusses how his company is navigating the pandemic.


Date: Jan 28, 2021


Questions for discussion:

  • From a financial point of view, does this report suggest Pfizer will have long term benefits from its investments in vaccines?
  • Should investors consider vaccines an important part of Pfizer’s portfolio?
  • What does the report suggest about the management of the firm?

Leave a Reply

Your email address will not be published. Required fields are marked *